Emmanuelle Charpentier, Jennifer A. Doudna Awarded Nobel Prize In Chemistry For Developing Crispr Gene-Editing Tool

Wall Street Journal: Nobel Prize in Chemistry Is Awarded for Crispr Gene-Editing Technology
“Two scientists won the Nobel Prize in Chemistry on Wednesday for discovering a powerful tool for genome editing that has enabled relatively quick and easy modification of the building blocks of life and promises new drugs for a range of diseases. France’s Emmanuelle Charpentier and American Jennifer A. Doudna shared the prize awarded by the Royal Swedish Academy of Sciences in Stockholm. Only five other women had ever received the award since its inception in 1901, bringing the total to seven out of 185 individuals…” (Abbott/Sugden, 10/7).

Additional coverage of the Nobel Prize in Chemistry is available from Nature, New York Times, TIME, and Washington Post.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.